The SAFE PACE episode with Alice Detollenaere and Antoine Tessier is probably the most important one we've recorded. Not the most spectacular — the most important. Because it addresses a question executive-athletes between 40 and 55 should ask seriously: what role does endurance play in cancer prevention and remission?
I'm not writing this article to sell a miracle protocol. I'm writing it because the data is solid, underused, and the silence around this topic costs lives.
What science establishes (without overinterpreting)
Recent meta-analyses (notably Moore et al., JAMA Internal Medicine 2016, and Friedenreich et al., 2021) converge on several points:
- Regular physical activity = 20 to 30% reduction in risk for several cancers: breast (post-menopause), colon, endometrium, kidney, esophagus.
- Dose-response effect up to 7.5 MET-h/week (≈ 2h30 of moderate activity). Beyond, additional benefit is marginal but real.
- Post-treatment benefit: 30 to 40% reduction in specific and all-cause mortality for breast cancer survivors maintaining moderate endurance activity.
Tessier reminds us: these aren't theoretical effects. They're robust data, validated on cohorts of hundreds of thousands of people.
The biological mechanisms (in plain terms)
Endurance sport doesn't "kill" cancer. It modifies the biological terrain on which cancer cells develop. Inflammation, insulin, immunity, tumor vascularization — everything is impacted.
— Antoine Tessier, SAFE PACE episode
Concretely, the main mechanisms:
- Reduction of low-grade chronic inflammation, fertile ground for carcinogenesis.
- Improved insulin sensitivity, which lowers IGF-1 levels (growth factor implicated in several cancers).
- Mobilization of NK (Natural Killer) cells, the immune system's first anti-tumor line.
- Hormonal regulation, particularly important in hormone-dependent cancers (breast, prostate).
Alice Detollenaere's testimony
Alice tells her breast cancer journey, from illness to remission, and the role sport played in her return to life — not just physiologically, but identity-wise. Her message is clear: sport during and after treatment isn't optional, it's a therapeutic pillar.
What struck me: her lucidity on the limits. Sport isn't a treatment substitute. It replaces no medical protocol. It's an efficacy multiplier, never a replacement. That nuance is essential in a world where "miracle" narratives cause damage.
The concrete protocol for the executive-athlete in prevention
The minimum effective dose (solid scientific evidence)
- 150 to 300 min/week of moderate-to-high endurance activity (3 to 5 sessions of 45 to 60 min).
- 2 strength sessions per week — muscle mass is protective independently of cardio.
- Daily mobility (10 to 15 min) — reduces systemic inflammation, improves lymphatic circulation.
- Regular sleep (7h+) — sleep is a major immune cofactor, without which sport benefits are halved.
What I tell the executives I coach
If you're 40 to 55, your parents had cancer, your weekday lifestyle is sedentary and you compensate with an intense weekend — you're exactly in the zone where investing in moderate endurance consistency pays the most. Not out of fear. Out of lucidity.
The goal isn't to run ultras. The goal is to maintain, over the next 30 years, a biological terrain unfavorable to chronic disease. It's probably the highest-yielding personal investment you can make — beyond any professional ROI.
And if you're going through the illness: talk to your oncologist about adapted physical activity (APA in France). It's now prescribed, reimbursed in some cases, and backed by all major medical societies. Don't stay alone with the question.